Neurology 1705 - Neurology Alert - May 01, 2013

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Physician Editor
Matthew Fink, MD
Interim Chair and Neurologist-in-Chief
Department of Neurology and Neuroscience
Weill Cornell Medical College
New York Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Anne Parrish Titzel Professor
Department of Neurology and Neuroscience
Weill Cornell Medical Center

Assistant Editor
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders
Weill Cornell Medical College

Dara Jamieson, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Claire Henchcliffe, MD, PhD
Associate Professor of Neurology and Neuroscience
Weill Cornell Medical College

Authors
Norman Latov, MD, PhD
Professor of Neurology
Department of Neurology
Professor of Neuroscience
Brain and Mind Research Institute
Weill Cornell Medical College

Jeffrey Gross, MD
Clinical Associate Professor of Rehabilitation Medicine
NYU School of Medicine
Adjunct Clinical Assistant Professor of Rehabilitation Medicine
Weill Cornell Medical College

Subjects:

  • Cholinergic Autonomic Dysfunction in Veterans with Gulf War Illness
  • Mild Head Strike May Have Lasting Impact on Children and Adolescents
  • Utility of Follow-Up MRI for Sciatica
  • Closure of Patent Foramen Ovale in Selected Patients with Cryptogenic Stroke May Be Better Than Medical Therapy Alone
  • Use of Ischemic Stroke Scores May Aid in the Prediction of Risk of Early Recurrence
  • Exercise Benefits Patients with Parkinson's Disease
  • One Step to Understanding Psychogenic Dystonia

Objectives:

  • discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • discuss the pathogenesis and treatment of pain
  • describe the basic science of brain function
  • discuss new information regarding new drugs for commonly diagnosed neurological conditions

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET.

Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball , Assistant editor Michael Rubin, MD, FRCP(C), and Author Jeffrey Gross, MD report no financial relationships relevant to this field of study.

Author Norman Latov, MD, PhD has served as a consultant to Griffols, Novartis, CSL Behring, Baxter Therapeutics, Pfizer, and Merck, and has stock in Therapath LLC.

Assistant editor Dara Jamieson, MD reports she is a retained consultant for Boehringer Ingelheim and Bayer, and is on the speakers bureau for Boehringer Ingelheim.

Assistant editor Claire Henchcliffe, MD, PhD reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmithKline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.

Copyright 2013 AHC Media. All rights reserved.